Paper42100675
"Artificial platelet injection system": a plug-and-play platelet-based lysosome-targeting chimera for targeted protein degradation.
Zou C and 3 others. Bioact Mater, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. "Artificial platelet injection system": a plug-and-play platelet-based lysosome-targeting chimera for targeted protein degradation. Papers, record 42100675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42100675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- "Artificial platelet injection system": a plug-and-play platelet-based lysosome-targeting chimera for targeted protein degradation.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19556463 | A gene network regulating lysosomal biogenesis and function. | Science | 2009 | https://conductscience.org/library/papers/19556463 | PubMed |
| 2 | 39225423 | Programming DNA Nanoassemblies into Polyvalent Lysosomal Degraders for Potent Degradation of Pathogenic Membrane Proteins. | Nano Lett | 2024 | https://conductscience.org/library/papers/39225423 | PubMed |
| 3 | 31692947 | Microfluidics for Advanced Drug Delivery Systems. | Curr Opin Chem Eng | 2015 | https://conductscience.org/library/papers/31692947 | PubMed |
| 4 | 33417864 | The Rise of Molecular Glues. | Cell | 2021 | https://conductscience.org/library/papers/33417864 | PubMed |
| 5 | 22367545 | Type VI secretion requires a dynamic contractile phage tail-like structure. | Nature | 2012 | https://conductscience.org/library/papers/22367545 | PubMed |
| 6 | 32728216 | Lysosome-targeting chimaeras for degradation of extracellular proteins. | Nature | 2020 | https://conductscience.org/library/papers/32728216 | PubMed |
| 7 | 9054390 | Systematic mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor cytoplasmic domain. An acidic cluster containing a key aspartate is important for function in lysosomal enzyme sorting. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9054390 | PubMed |
| 8 | 36991127 | Programmable protein delivery with a bacterial contractile injection system. | Nature | 2023 | https://conductscience.org/library/papers/36991127 | PubMed |
| 9 | 34596400 | Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/34596400 | PubMed |
| 10 | 36706761 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36706761 | PubMed |
| 11 | 11277922 | Receptor mediated uptake of peptides that bind the human transferrin receptor. | Eur J Biochem | 2001 | https://conductscience.org/library/papers/11277922 | PubMed |
| 12 | 39322662 | Designed endocytosis-inducing proteins degrade targets and amplify signals. | Nature | 2025 | https://conductscience.org/library/papers/39322662 | PubMed |
| 13 | 38885002 | Platelet-Drug Conjugates Engineered via One-step Fusion Approach for Metastatic and Postoperative Cancer Treatment. | Angew Chem Int Ed Engl | 2024 | https://conductscience.org/library/papers/38885002 | PubMed |
| 14 | 8226743 | Mutational analysis of the cation-independent mannose 6-phosphate/insulin-like growth factor II receptor. A consensus casein kinase II site followed by 2 leucines near the carboxyl terminus is important for intracellular targeting of lysosomal enzymes. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8226743 | PubMed |
| 15 | 38040850 | The dynamic role of platelets in cancer progression and their therapeutic implications. | Nat Rev Cancer | 2024 | https://conductscience.org/library/papers/38040850 | PubMed |
| 16 | 39468359 | Targeted protein degradation via cellular trafficking of nanoparticles. | Nat Nanotechnol | 2025 | https://conductscience.org/library/papers/39468359 | PubMed |
| 17 | 38001393 | Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology. | Nat Rev Mol Cell Biol | 2024 | https://conductscience.org/library/papers/38001393 | PubMed |
| 18 | 35042991 | PROTAC targeted protein degraders: the past is prologue. | Nat Rev Drug Discov | 2022 | https://conductscience.org/library/papers/35042991 | PubMed |
| 19 | 40916240 | Blockade of metastasis by targeting circulating tumor cells with platelet encapsuled oncolytic adenovirus. | Biomaterials | 2026 | https://conductscience.org/library/papers/40916240 | PubMed |
| 20 | 29632369 | A type VI secretion system effector delivery mechanism dependent on PAAR and a chaperone-co-chaperone complex. | Nat Microbiol | 2018 | https://conductscience.org/library/papers/29632369 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD274 | 29126 | PubTator's text mining | https://conductscience.org/library/genes/29126 | NCBI Gene |
| NAAA | 27163 | PubTator's text mining | https://conductscience.org/library/genes/27163 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42100675
GET https://conductscience.org/api/papers/v1/42100675/references?page=2